CIBC Private Wealth Group’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,939
| Closed | -$2.29K | – | 3098 |
|
|
2025
Q1 | $2.29K | Hold |
3,939
| – | – | ﹤0.01% | 2648 |
|
|
2024
Q4 | $4.39K | Hold |
3,939
| – | – | ﹤0.01% | 2508 |
|
|
2024
Q3 | $6.74K | Hold |
3,939
| – | – | ﹤0.01% | 2515 |
|
|
2024
Q2 | $4.61K | Hold |
3,939
| – | – | ﹤0.01% | 2539 |
|
|
2024
Q1 | $3.5K | Buy |
+3,939
| New | +$6.22K | ﹤0.01% | 2607 |
|
|
2023
Q3 | – | Sell |
-3,942
| Closed | -$31.9K | – | 1083 |
|
|
2023
Q2 | $31.9K | Hold |
3,942
| – | – | ﹤0.01% | 863 |
|
|
2023
Q1 | $27.6K | Hold |
3,942
| – | – | ﹤0.01% | 874 |
|
|
2022
Q4 | $28 | Buy |
3,942
+994
| +34% | +$10.9K | ﹤0.01% | 847 |
|
|
2022
Q3 | $45K | Sell |
2,948
-10
| -0.3% | -$166 | ﹤0.01% | 892 |
|
|
2022
Q2 | $29K | Hold |
2,958
| – | – | ﹤0.01% | 991 |
|
|
2022
Q1 | $43K | Hold |
2,958
| – | – | ﹤0.01% | 1048 |
|
|
2021
Q4 | $154K | Sell |
2,958
-20
| -0.7% | -$1.11K | ﹤0.01% | 985 |
|
|
2021
Q3 | $174K | Sell |
2,978
-100
| -3% | -$6.52K | ﹤0.01% | 904 |
|
|
2021
Q2 | $248K | Buy |
3,078
+10
| +0.3% | +$795 | ﹤0.01% | 947 |
|
|
2021
Q1 | $255K | Sell |
3,068
-266
| -8% | -$27K | ﹤0.01% | 943 |
|
|
2020
Q4 | $253K | Sell |
3,334
-114
| -3% | -$10.2K | ﹤0.01% | 902 |
|
|
2020
Q3 | $368K | Buy |
+3,448
| New | +$479K | ﹤0.01% | 737 |
|
|
2020
Q2 | – | Sell |
-4,069
| Closed | -$339K | – | 605 |
|
|
2020
Q1 | $339K | Sell |
4,069
-488
| -11% | -$68.7K | ﹤0.01% | 687 |
|
|
2019
Q4 | $770K | Sell |
4,557
-110
| -2% | -$18.2K | ﹤0.01% | 629 |
|
|
2019
Q3 | $867K | Sell |
4,667
-118
| -2% | -$22.8K | ﹤0.01% | 598 |
|
|
2019
Q2 | $1.09M | Sell |
4,785
-279
| -6% | -$54.6K | ﹤0.01% | 563 |
|
|
2019
Q1 | $1.06M | Sell |
5,064
-95
| -2% | -$17.8K | ﹤0.01% | 575 |
|
|
2018
Q4 | $593K | Sell |
5,159
-918
| -15% | -$136K | ﹤0.01% | 653 |
|
|
2018
Q3 | $1.4M | Buy |
6,077
+22
| +0.4% | +$4.86K | 0.01% | 601 |
|
|
2018
Q2 | $1.35M | Buy |
6,055
+1,530
| +34% | +$342K | 0.01% | 592 |
|
|
2018
Q1 | $1.03M | Sell |
4,525
-141
| -3% | -$37K | ﹤0.01% | 639 |
|
|
2017
Q4 | $1.22M | Sell |
4,666
-3
| -0.1% | -$703 | 0.01% | 616 |
|
|
2017
Q3 | $1.05M | Buy |
+4,669
| New | +$1.15M | ﹤0.01% | 627 |
|
Other funds holding AXDX
CIBC Private Wealth Group's AXDX Position: Q2 2025 in Review
CIBC Private Wealth Group sold out of Accelerate Diagnostics (AXDX) in Q2 2025, closing a stake of 3,939 shares — an estimated $2.29K sold.
CIBC Private Wealth Group first reported a position in AXDX in Q3 2017 and held it in 28 quarters. The position peaked at $1.4M in Q3 2018. 3 funds tracked by Wall St. Rank hold AXDX as of Q2 2025.
- CIBC Private Wealth Group reported no remaining Accelerate Diagnostics position as of Q2 2025 after selling out during the quarter.
- CIBC Private Wealth Group sold 3,939 Accelerate Diagnostics shares in Q2 2025, an estimated $2.29K.
- CIBC Private Wealth Group first reported a position in Accelerate Diagnostics in Q3 2017 and held it in 28 quarters.
- CIBC Private Wealth Group's Accelerate Diagnostics position peaked at $1.4M in Q3 2018.
- 3 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2025.
Based on CIBC Private Wealth Group's 13F filing for Q2 2025, filed 12 Aug 2025.